Praxis Precision Medicines (PRAX) Revenue (Gross): 2024-2025
Historic Revenue (Gross) for Praxis Precision Medicines (PRAX) over the last 2 years, with Sep 2025 value amounting to $4.4 million.
- Praxis Precision Medicines' Revenue (Gross) fell 10.15% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.1 million, marking a year-over-year change of. This contributed to the annual value of $17.3 million for FY2024, which is 460.27% up from last year.
- As of Q3 2025, Praxis Precision Medicines' Revenue (Gross) stood at $4.4 million, which was down 10.43% from $4.9 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Revenue (Gross) ranged from a high of $5.4 million in Q1 2025 and a low of $2.3 million during Q1 2024.
- Moreover, its 2-year median value for Revenue (Gross) was $4.9 million (2024), whereas its average is $4.6 million.
- Within the past 5 years, the most significant YoY rise in Praxis Precision Medicines' Revenue (Gross) was 132.93% (2025), while the steepest drop was 10.15% (2025).
- Quarterly analysis of 2 years shows Praxis Precision Medicines' Revenue (Gross) stood at $5.3 million in 2024, then decreased by 10.15% to $4.4 million in 2025.
- Its Revenue (Gross) was $4.4 million in Q3 2025, compared to $4.9 million in Q2 2025 and $5.4 million in Q1 2025.